Management of the Patient With Androgen-Independent Metastatic Prostate Cancer
Reference48 articles.
1. Jemal A, Murray T, Samels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.
2. Scher H, Steineck G, Kelly W. Hormone-refractory prostate cancer: refining the concept. Urology 1995; 46: 142–148.
3. Gittes R. Carcinoma of the prostate. N Engl J Med 1991; 324: 236–245.
4. Kelly WK, Scher HI. Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome. J Urol 1993; 149: 607–609.
5. Kelly WK, Slovin S, Scher HI. Steroid hormone withdrawal syndromes. Pathophysiology and clinical significance. Urol Clin North Am 1997; 24: 421–431.